Disease control of patients with newly screening-detected hyperuricemia: A retrospective cohort study of health insurance claims and medical check-up data
Not Applicable
- Conditions
- Gout, hyperuricemia
- Registration Number
- JPRN-UMIN000039985
- Lead Sponsor
- Teijin Pharma Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15000
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who identified gout or asymptomatic hyperuricemia during the index period 2. Patients who received prescriptions of urate-lowering therapy during the index period 3. Patients who identified malignant neoplasms during the index period
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method